SETD2 and cancer: An increase in the expression of GLUT transporters is positively correlated with the increased expression of other glycolytic enzymes, which suggests an interplay between HIF-1, GLUTs, and glucose-metabolism-related enzymes associated with host metabolic reprogramming in diseases such as cancer and those mediated by oncogenic viruses [28,29,30].